查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1965344

鐵蛋白檢測市場 - 全球產業規模、佔有率、趨勢、機會、預測：按產品、應用、最終用途、地區和競爭對手分類，2021-2031年

Ferritin Testing Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Application, By End Use, By Region & Competition, 2021-2031F
出版日期: | 出版商: TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球鐵蛋白檢測市場預計將從 2025 年的 16.7 億美元成長到 2031 年的 25.9 億美元，複合年成長率為 7.59%。

血清鐵蛋白檢測是重要的臨床診斷工具，它能夠量化血清鐵蛋白水平，從而清晰評估全身鐵蘊藏量，並識別貧血和鐵過載等疾病。營養缺乏症發病率的上升以及慢性疾病（如腎衰竭）管理中對鐵監測的迫切需求，推動了這個市場的發展。根據美國血液學會2024年的數據，美國青少年和年輕女性的缺鐵盛行率可能高達39%，凸顯了對診斷干預措施的巨大需求。

市場概覽
預測期 2027-2031
市場規模：2025年 16.7億美元
市場規模：2031年 25.9億美元
複合年成長率：2026-2031年 7.59%
成長最快的細分市場 成套工具
最大的市場 北美洲

儘管成長要素強勁，但市場仍面臨一個重大障礙：用於精確檢測的自動化免疫檢測系統高成本。新興經濟體缺乏先進的檢查室基礎設施，進一步加劇了這項資金限制，導致鐵蛋白檢測的普及程度降低。因此，這些經濟和基礎設施障礙限制了發展中地區的市場准入，阻礙了整體成長，儘管臨床上對鐵監測的需求十分明確。

市場促進因素

全球缺鐵性貧血盛行率的上升正成為市場擴張的主要催化劑，也使得頻繁的診斷篩檢成為避免長期健康併發症的迫切需求。顯性貧血和隱性缺鐵之間的差距擴大了目標人口，並促使鐵蛋白檢測成為常規檢查項目。美國血液學會於2025年11月發布的一項系統性綜述報告稱，在不同的鐵蛋白閾值下，缺鐵的合併盛行率為30%，這表明存在大量未確診的患者群體。這項數據，結合美國疾病管制與預防中心（CDC）2024年的數據（2歲及以上族群的貧血總體盛行率為9.3%），凸顯了血液學監測的根本需求，而這正是全球市場發展的基石。

老年人口的快速成長，尤其是慢性腎臟病等慢性疾病的易感族群，進一步加劇了對精準鐵蛋白監測的需求。對於合併多種疾病的老年患者，區分缺鐵性貧血和慢性病相關性貧血對於採取適當的治療措施至關重要。發表於2025年1月《營養學雜誌》的一項研究發現，27.2%的非透析慢性腎臟病患者的鐵蛋白水平低於100 ng/mL，這凸顯了對該人群鐵蘊藏量進行仔細評估的必要性。隨著醫療系統將慢性病管理置於優先地位以降低再入院率，鐵蛋白檢測作為老年照護核心診斷工具的重要性也日益凸顯。

市場挑戰

全球鐵蛋白檢測市場擴張的主要障礙是自動化免疫檢測系統的高昂成本，而發展中地區檢測基礎設施的匱乏更使這問題雪上加霜。精確的鐵蛋白測量需要複雜的診斷平台，這需要大量的初始資本投入和持續的營運資金。在醫療預算有限的新興經濟體，這種經濟負擔阻礙了關鍵設備的廣泛應用，實際上將需要鐵監測的潛在患者群體排除在外。

監管合規和設備維護成本的不斷上漲加劇了這一經濟負擔，迫使製造商將這些成本轉嫁給檢測實驗室。根據 MedTech Europe 發布的 2025 年行業調查報告，體外診斷設備製造商預計將面臨相當於標準認證週期內初始認證成本 70% 的維護和再認證成本。這些不斷上漲的成本推高了自動化系統的總擁有成本，使其對於資源有限的機構而言在經濟上不可行。因此，儘管缺鐵症的盛行率不斷上升，市場仍難以滲透到需求旺盛的開發中國家，這直接阻礙了全球收入成長。

市場趨勢

家用和自測檢測套組的普及檢測套組從根本上改變市場結構，使診斷服務分散化，並創造了一個患者無需前往臨床檢查室即可自行監測鐵蘊藏量的環境。這一趨勢主要得益於面向消費者的數位化銷售管道的成長，這些管道繞過了傳統醫療保健系統的瓶頸，使個人能夠直接訂購和接受診斷試劑盒。毛細血管採血的簡單性和數位化結果交付的便利性吸引了注重健康的消費者，並有效地規避了集中檢測的基礎設施限制。例如，Quest Diagnostics 在 2025 年 1 月的財報中宣布，其以消費者主導的平台將擴展其檢測範圍至約 135 種，包括微量營養素缺乏症，並增強對基本代謝監測的可及性。

同時，基於智慧型手機的診斷平台的整合正在徹底改變鐵蛋白定量檢測的速度和成本，尤其是在資源匱乏的環境中。透過利用標準行動裝置的高解析度成像功能，開發人員正在創建比色分析工具，從而無需昂貴的固定式光強度。這些攜帶式解決方案使用客製化應用程式分析微流體試紙上的反應變化，即使在非檢測環境下也能提供即時的臨床數據。正如《康乃爾紀事報》2024年12月報道，基於智慧型手機的診斷技術「AnemiaPhone」已正式移交給印度醫學研究委員會，實現了對缺鐵的快速現場篩檢。這充分展現了行動互聯診斷技術的擴充性。

目錄

第1章概述

第2章：調查方法

第3章執行摘要

第4章：客戶心聲

第5章：全球鐵蛋白檢測市場展望

  • 市場規模及預測
    • 按金額
  • 市佔率及預測
    • 依產品分類（儀器、試劑、試劑盒）
    • 依用途（貧血、血鐵沉著症、鉛中毒、懷孕、其他）
    • 依最終用戶（醫院、診斷檢查室）分類
    • 按地區
    • 按公司（2025 年）
  • 市場地圖

第6章：北美鐵蛋白檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國別分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲鐵蛋白檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國別分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區鐵蛋白檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國別分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲鐵蛋白檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東與非洲：國別分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲鐵蛋白檢測市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國別分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章 市場動態

  • 促進因素
  • 任務

第12章 市場趨勢與發展

  • 併購
  • 產品發布
  • 近期趨勢

第13章：全球鐵蛋白檢測市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的議價能力
  • 顧客權力
  • 替代品的威脅

第15章 競爭格局

  • Eurolyser Diagnostica GmbH
  • Cortez Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Biomerieux SA
  • Aviva Systems Biology Corporation
  • Abnova Corporation
  • CTK Biotech Inc.
  • Randox Laboratories Ltd.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • F. Hoffmann-La Roche Ltd.

第16章 策略建議

第17章：關於研究公司及免責聲明

簡介目錄
Product Code: 27300

The Global Ferritin Testing Market is projected to expand from USD 1.67 Billion in 2025 to USD 2.59 Billion by 2031, registering a CAGR of 7.59%. Ferritin testing serves as a critical clinical diagnostic method for quantifying serum ferritin levels, offering a definitive evaluation of total body iron reserves to identify conditions such as anemia or iron overload. The market is consistently driven by the rising incidence of nutritional deficiencies and the essential requirement for iron monitoring in the management of chronic diseases like renal failure. Data from the American Society of Hematology in 2024 indicates that the prevalence of iron deficiency among adolescent and young adult women in the United States could be as high as 39%, highlighting the substantial demand for diagnostic intervention.

Market Overview
Forecast Period2027-2031
Market Size 2025USD 1.67 Billion
Market Size 2031USD 2.59 Billion
CAGR 2026-20317.59%
Fastest Growing SegmentKits
Largest MarketNorth America

Despite these strong growth factors, the market faces a major hurdle due to the high costs associated with the automated immunoassay systems needed for precise testing. This financial constraint, exacerbated by a lack of advanced laboratory infrastructure in emerging economies, restricts the availability of ferritin testing. Consequently, these economic and infrastructural barriers limit market accessibility in developing regions, constraining overall growth despite the clear clinical need for iron monitoring.

Market Driver

The increasing global prevalence of iron deficiency anemia acts as a primary catalyst for market expansion, creating a pressing need for frequent diagnostic screening to avert long-term health complications. The gap between overt anemia and latent iron deficiency expands the target population for testing, encouraging the routine adoption of ferritin assays. A November 2025 systematic review by the American Society of Hematology revealed a pooled iron deficiency prevalence of 30% across various ferritin thresholds, suggesting a large, under-diagnosed patient pool. This figure, combined with 2024 data from the Centers for Disease Control and Prevention showing a 9.3% overall anemia prevalence in individuals aged two and older, reinforces the fundamental demand for hematological monitoring that supports the global market.

The rapidly growing geriatric population, which is susceptible to chronic ailments such as chronic kidney disease, further accelerates the demand for accurate ferritin monitoring. In elderly patients with complex comorbidities, distinguishing between iron deficiency anemia and anemia of chronic disease is vital for proper therapeutic action. A January 2025 study in the Nutrition Journal reported that 27.2% of non-dialysis chronic kidney disease patients had ferritin levels at or below 100 ng/mL, emphasizing the necessity for vigilant iron store evaluation in this demographic. As healthcare systems increasingly prioritize the management of chronic conditions to reduce hospital readmissions, the reliance on ferritin testing as a core diagnostic tool in geriatric care continues to intensify.

Market Challenge

The main impediment to the expansion of the Global Ferritin Testing Market is the prohibitive expense associated with automated immunoassay systems, compounded by a shortage of adequate laboratory infrastructure in developing regions. Precise ferritin measurement relies on advanced diagnostic platforms that require significant upfront capital investment and substantial ongoing operational funding. In emerging economies where healthcare budgets are often limited, this financial burden hinders the widespread installation of necessary equipment, creating an entry barrier that effectively excludes a large demographic of potential patients who require iron monitoring.

This economic strain is further intensified by the escalating costs of regulatory compliance and device maintenance, which manufacturers inevitably pass on to laboratories. Industry survey findings from MedTech Europe in 2025 project that manufacturers of in vitro diagnostics will face maintenance and re-certification costs that are 70% higher than initial certification fees over a standard cycle. These rising expenses increase the total cost of ownership for automated systems, making them financially unviable for resource-constrained facilities. Consequently, the market struggles to penetrate high-need developing nations, directly hampering global revenue growth despite the rising prevalence of iron deficiency.

Market Trends

The proliferation of at-home and self-testing kits is fundamentally reshaping the market by decentralizing diagnostic access and empowering patients to monitor iron stores without visiting clinical laboratories. This trend is largely supported by the growth of direct-to-consumer digital sales channels, which allow individuals to order and receive diagnostic kits directly, bypassing traditional healthcare bottlenecks. The convenience of capillary blood collection combined with digital result delivery appeals to health-conscious demographics, effectively circumventing the infrastructure limitations of centralized testing. For instance, Quest Diagnostics reported in their January 2025 financial results that their consumer-initiated platform had expanded to cover approximately 135 tests, including micronutrient deficiencies, thereby broadening access to essential metabolic monitoring.

Simultaneously, the integration of smartphone-based diagnostic platforms is revolutionizing the speed and affordability of ferritin quantification, particularly in resource-limited settings. By leveraging the high-resolution imaging capabilities of standard mobile devices, developers are creating colorimetric analysis tools that eliminate the need for expensive, stationary spectrophotometers. These portable solutions utilize custom applications to analyze reaction changes on microfluidic strips, offering immediate clinical data in non-laboratory environments. As highlighted by the Cornell Chronicle in December 2024, a smartphone-based diagnostic technology named AnemiaPhone was formally transferred to the Indian Council of Medical Research to enable rapid, point-of-need screening for iron deficiency, illustrating the scalability of mobile-linked diagnostics.

Key Market Players

  • Eurolyser Diagnostica GmbH
  • Cortez Diagnostics Inc.
  • Thermo Fisher Scientific Inc.
  • Biomerieux S.A
  • Aviva Systems Biology Corporation
  • Abnova Corporation
  • CTK Biotech Inc.
  • Randox Laboratories Ltd.
  • Guangzhou Wondfo Biotech Co., Ltd.
  • F. Hoffmann-La Roche Ltd.

Report Scope

In this report, the Global Ferritin Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Ferritin Testing Market, By Product

  • Instrument
  • Reagent
  • Kits

Ferritin Testing Market, By Application

  • Anaemia
  • Hemochromatosis
  • Lead Poisoning
  • Pregnancy
  • Others

Ferritin Testing Market, By End Use

  • Hospitals
  • Diagnostic Laboratories

Ferritin Testing Market, By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Ferritin Testing Market.

Available Customizations:

Global Ferritin Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Ferritin Testing Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Instrument, Reagent, Kits)
    • 5.2.2. By Application (Anaemia, Hemochromatosis, Lead Poisoning, Pregnancy, Others)
    • 5.2.3. By End Use (Hospitals, Diagnostic Laboratories)
    • 5.2.4. By Region
    • 5.2.5. By Company (2025)
  • 5.3. Market Map

6. North America Ferritin Testing Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By End Use
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Ferritin Testing Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End Use
    • 6.3.2. Canada Ferritin Testing Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End Use
    • 6.3.3. Mexico Ferritin Testing Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End Use

7. Europe Ferritin Testing Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By End Use
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Ferritin Testing Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End Use
    • 7.3.2. France Ferritin Testing Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End Use
    • 7.3.3. United Kingdom Ferritin Testing Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End Use
    • 7.3.4. Italy Ferritin Testing Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End Use
    • 7.3.5. Spain Ferritin Testing Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End Use

8. Asia Pacific Ferritin Testing Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By End Use
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Ferritin Testing Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End Use
    • 8.3.2. India Ferritin Testing Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End Use
    • 8.3.3. Japan Ferritin Testing Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End Use
    • 8.3.4. South Korea Ferritin Testing Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End Use
    • 8.3.5. Australia Ferritin Testing Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End Use

9. Middle East & Africa Ferritin Testing Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By End Use
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Ferritin Testing Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End Use
    • 9.3.2. UAE Ferritin Testing Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End Use
    • 9.3.3. South Africa Ferritin Testing Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End Use

10. South America Ferritin Testing Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By End Use
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Ferritin Testing Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End Use
    • 10.3.2. Colombia Ferritin Testing Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End Use
    • 10.3.3. Argentina Ferritin Testing Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Ferritin Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Eurolyser Diagnostica GmbH
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. Cortez Diagnostics Inc.
  • 15.3. Thermo Fisher Scientific Inc.
  • 15.4. Biomerieux S.A
  • 15.5. Aviva Systems Biology Corporation
  • 15.6. Abnova Corporation
  • 15.7. CTK Biotech Inc.
  • 15.8. Randox Laboratories Ltd.
  • 15.9. Guangzhou Wondfo Biotech Co., Ltd.
  • 15.10. F. Hoffmann-La Roche Ltd.

16. Strategic Recommendations

17. About Us & Disclaimer